Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis
SGLT-2i are associated with AP. Given the rising prescription of SGLT-2i, physicians should consider these agents as a potential cause of pancreatitis after excluding other etiologies.
Authors
- Ronghui Li (ORCID: https://orcid.org/0009-0002-4407-4602)
- Yang He (ORCID: https://orcid.org/0000-0003-1788-4108)
- Panpan Luo
- Chunjiang Wang (ORCID: https://orcid.org/0000-0002-8490-0131)
- Yuge Guo
Institutions
- Central South University (CN)
- Changsha Medical University (CN)
- First Affiliated Hospital of Hunan University of Traditional Chinese Medicine (CN)
- Xiangyang Central Hospital (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-08-22
- DOI
- https://doi.org/10.1080/14740338.2024.2396387
- Citations
- 67
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 38.38
Funders
- Natural Science Foundation of Hunan Province